Our pioneering LiDia-SEQ™ DNA sequencing system will host a range of tests that will provide vital, actionable information to clinicians at the point-of-need, helping save patients’ lives.
For Research Use Only. Not for use in diagnostic procedures. For illustrative purposes only.
VERSATILE PLATFORM
LiDia-SEQ™ combines powerful analytical capability and accurate results with speed and simplicity of use.
Diagnostic tests are in development for multiple healthcare applications where rapid point-of-need diagnostics are of critical need:
Bloodstream infection (BSI) pathogen identification
Antimicrobial resistance
Viral and pandemic
Liquid biopsy for diagnostics and monitoring
SIMPLE
Easy to operate
providing 24/7
diagnostics
FAST
Results in 3-4 hours
at the point of need
ACCURATE
Highly sensitive and
specific
OUR LEADING PROGRAM
The initial application focus for the LiDia-SEQ™ system is infectious disease diagnostics, where speed and DNA sequence information can make the difference between life and death. The target range of tests include a groundbreaking test for bloodstream infections (BSI) and antimicrobial resistance (AMR), using whole blood specimens to detect and identity infections that lead to sepsis.
The diagnostic will rapidly identify what infection a patient has, as well as any associated antimicrobial resistance. This will provide clinicians with actionable information to help select the appropriate antibiotics to treat the disease.
For Research Use Only. Not for use in diagnostic procedures. For illustrative purposes only.
Three simple steps
